K Borchert

Forty-one recent cases of invasive zygomycosis from a global clinical registry

Maria J. G. T. Rüping, Werner Heinz, A. J. Kindo et al. · Journal of Antimicrobial Chemotherapy · 2009 · 199 citations · Full text

Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis

Johann Ockenga, K Borchert, K. Rifai et al. · Clinical Nutrition · 2002 · 110 citations

Nutrition, Nutritional Requirement, Biochemical Nutrition +7

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Markus Moehler, Annett Maderer, Peter Thuss‐Patience et al. · Annals of Oncology · 2020 · 110 citations

FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2–Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

Ralf‐Dieter Hofheinz, Kirsten Merx, Georg Martin Haag et al. · Journal of Clinical Oncology · 2022 · 86 citations

Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO.

Ralf‐Dieter Hofheinz, Georg Martin Haag, Thomas J. Ettrich et al. · Journal of Clinical Oncology · 2020 · 83 citations

Surgical Oncology, Esophageal Cancer, Cancer Management +16